ReviewMicrobial biotechnology2026
Next-Generation Microencapsulation Technologies for Probiotic Protection and Precision Delivery.
Review in Microbial biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Recent Advances in Polysaccharide-Based Encapsulation of Probiotics: Encapsulation Technologies, Material Properties, and Applications in Dairy Products.Foods (Basel, Switzerland) · 2026Review
- Recent Advances in Encapsulation Strategies for Synbiotic Formulation ContainingMicroorganisms · 2026Review
- Technological Innovation and Consumer Trust: Understanding Safety Perceptions in Next Generation Probiotic Development.Microorganisms · 2026Article
- Engineered live bacteria for liver diseases and gut-liver axis disorders: from genetic modification to advanced delivery systems.Journal of nanobiotechnology · 2026Review
- Biotechnological Potential of Quorum Quenching Bacterial Strains Isolated fromAnimals : an open access journal from MDPI · 2026Article
- Dietary Encapsulation of a NovelAntioxidants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Probiotics offer well-documented benefits, including improved gastrointestinal function, microbiota modulation, and immune enhancement. However, their therapeutic potential is limited by poor survival during oral delivery due to gastric acid, bile salts, and pathological gut conditions. Microencapsulation has emerged as a transformative strategy to enhance probiotic viability by shielding them from environmental stressors. This review comprehensively examines cutting-edge microencapsulation materials and innovative techniques that improve probiotic stability under thermal, oxidative, and gastrointestinal stresses. We highlight advanced delivery systems, such as pH-responsive and inflammation-targeted microcapsules, which enable precise intestinal release and enhanced colonisation. Additionally, we critically assess safety considerations and industrial scalability challenges, emphasising the need for biocompatible materials and cost-effective production. By integrating recent breakthroughs with practical applications, this review underscores the potential of next-generation microencapsulation to enable safer, more efficient, and personalised probiotic therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.